Overview

Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver

Status:
Unknown status

Trial end date:
2020-07-30

Target enrollment:

Participant gender:

Summary

Pilot study to assess the antiviral activity and safety of Besifovir dipivoxil 150mg and L-carnitine 660mg compared to Tenofovir Alafenamide 25mg in chronic hepatitis B patients with Nonalcoholic fatty liver

Phase:

Phase 4

Details

Lead Sponsor:

IlDong Pharmaceutical Co Ltd

Treatments:

Tenofovir